ISSN: 2090-3111

Journal Home

Prostate Cancer Q3 Unclaimed

Hindawi Limited Egypt

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Prostate Cancer is a journal indexed in SJR in Oncology and Cancer Research with an H index of 15. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 922,5 €. The scope of the journal is focused on male urogenital diseases, prostatic neoplasms, prostate cancer. It has an SJR impact factor of 0,305 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,305.

Type: Journal

Type of Copyright: CC BY

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Oncology (Q3) Urology (Q3) Cancer Research (Q4)

Price

922,5 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,305

SJR Impact factor

15

H Index

2

Total Docs (Last Year)

33

Total Docs (3 years)

99

Total Refs

37

Total Cites (3 years)

33

Citable Docs (3 years)

0.76

Cites/Doc (2 years)

49.5

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Cancer Management and Research Q3
Journal of Breast Cancer Q3
Breast Cancer: Basic and Clinical Research Q3
Oncology Letters Q3
Clinical Medicine Insights: Oncology Q3

Compare this journals

Aims and Scope

Male urogenital diseases Prostatic neoplasms Prostate cancer